MONTREAL, QUEBEC--(Marketwire - August 05, 2008) - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announces today that it has reached an understanding with a fully integrated, U.S.-based, biotechnology company with respect to the development and global commercialization of several biopharmaceutical products in ProMetic's Protein Technology Division.
